New York State Medicaid Drug Benefit Transfer, on Ice for Two Years, Is Back

Mark Malahosky pictured with March for 340B placard
“It’s not hyperbole to say if this is put into place, we’re going to have to cut services and cut staffing," Mark Malahosky of Trillium Health says of New York State's plan to shift Medicaid managed care prescription drug benefits into Medicaid fee for service.

With a two-year implementation delay nearly over, New York State is poised to fold its Medicaid managed care prescription drug benefits into its Medicaid fee for service system on April 1. State 340B health care providers that serve high volumes

Read More »

Guthrie and Griffith, as Expected, Will Helm House E&C Subcommittees Involved in 340B

U.S. Rep. Brett Guthrie (R-KY) and Rep. Morgan Griffith (R-VA) headshots
U.S. Rep. Brett Guthrie (left) (R-Ky.) will chair the Energy & Commerce Subcommittee on Health and Rep. Morgan Griffith (R-Va.) the Subcommittee on Oversight and Investigations.

U.S. House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.) yesterday as expected announced that Rep. Brett Guthrie (R-Ky.) will chair the Subcommittee on Health and Rep. Morgan Griffith (R-Va.) the Subcommittee on Oversight and Investigations.

Guthrie said

Read More »

340B INDUSTRY LEADER SPOTLIGHT

ShaiAnn Howard, Director, Health Systems Solutions & Decision Science, AllianceRx Walgreens Pharmacy

ShaiAnn Howard, 340B Director, Alliance Rx Walgreens Pharmacy
ShaiAnn Howard

Q: Where did you grow up?

I grew up in Racine, WI. I have lived in Wisconsin my entire life.

Q: Where did you go to college?

I attended Marquette University in Milwaukee, WI.

Q: What are your favorites?

Food: Tacos

Movie: All of the Harry Potter films

Musicians: Lady Gaga, Elvis Presley and Pink

Destination:

Read More »

House GOP Bill Would Stop Additional Hospitals and Child Sites from 340B Enrollment and Make it Harder for Current Hospitals to Remain Eligible

U.S. Rep. Matt Rosendale (R-MT)
U.S. Rep. Matt Rosendale (R-Mont.) has reintroduced a bill to put a moratorium on 340B hospital growth, impose 340B reporting requirements on hospitals, and make it harder for private nonprofit hospitals to stay in 340B.

A new U.S. House bill would put a moratorium on 340B hospital growth and impose a host of reporting requirements on 340B hospitals. It would also make it much harder for private nonprofit hospitals to remain in the 340B program.

Read More »

U.S. House Leaders Agree on Committee Ratios: Energy & Commerce Gets to Work 

Screenshot of Energy and Commerce welcome splash screen
The composition of the House Energy & Commerce Committee in this Congress is clear now that party leaders have agreed on committee sizes and ratios.

U.S. House Speaker Kevin McCarthy (R-Calif.) and Minority Leader Hakeem Jeffries (D-N.Y.) have reached an agreement on the balance of power in committees during this Congress and are expected to formally assign members to committees as soon as this week.

Read More »

Astellas Notifies 340B Entities About Antifungal’s Updated NDC

Astellas wordmark on building
Astellas says the old and new NDCs for its antifungal drug Cresemba are interchangeable in compliant 340B inventory replenishment models.

Drug manufacturer Astellas will let 340B covered entities using “a compliant 340B inventory replenishment model” count accumulations of its antifungal Cresemba under its old National Drug Code toward replenishment of equal quantities under the product’s corresponding new NDC, the company

Read More »

End 340B, Commentary in New England Journal of Medicine Suggests

Screenshot of commentary on Medicare overpayment for outpatient medication in the NEJM
Policymakers should consider disbanding the 340B program, a student and a professor at the Stanford University School of Medicine say in the New England Journal of Medicine.

Policymakers should consider disbanding the 340B program “given its negative reverberations for patients and markets,” a student and a professor at the Stanford University School of Medicine wrote in a commentary in the latest edition of the New England Journal

Read More »

MedPAC Votes to Recommend Ditching Medicare DSH Patient Percentage for Medicare Purposes

MedPAC wordmark
MedPAC thinks CMS should stop using the Medicare DSH patient percentage for Medicare purposes. The 340B program uses the DSH calculation for hospital eligibility purposes.

The Medicare Payment Advisory Commission, as expected, has voted to recommend that Congress should start phasing in a new way of distributing extra Medicare payments to safety net hospitals that disproportionately serve low-income and/or uninsured beneficiaries.

The proposal that

Read More »

The Mpox Outbreak: What a Swift Response Looks Like

Asha Doucet headshot on light blue background

SPONSORED CONTENT

The monkeypox (renamed mpox by the World Health Organization) outbreak took the world by storm in early May of 2022 on the heels of the COVID-19 pandemic. The AIDS Healthcare Foundation (AHF) was among the first public health organizations to sound the

Read More »

Ryan White Clinics for 340B Access Is Dropping its 340B Dispute Resolution Lawsuit

RWC-340B wordmark
RWC-340B is dropping is lawsuit that helped prod HRSA to issue long-delayed 340B dispute resolution rules.

Ryan White Clinics for 340B Access is dropping its lawsuit that, together with a related case, led federal health officials to issue long-delayed dispute resolution rules for the 340B program in December 2020.

RWC-340B, five co-plaintiff 340B covered entities, and

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live